Recruiting
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
The purpose of this study is to improve ways of providing mental health support to Spanish-speaking Latino participants who have cancer and experience depression, insomnia, and fatigue. Investigators will test a special mental health intervention called DESCANSO/REST (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep). The intervention can be delivered through telehealth.
ClinicalTrials.gov IDNCT07225088
PhaseNA
Enrollment125
SponsorMemorial Sloan Kettering Cancer Center
Age21 Years
SexALL
Conditions studied
Solid Tumor, Solid Tumor, Adult
About this study
The purpose of this study is to improve ways of providing mental health support to Spanish-speaking Latino participants who have cancer and experience depression, insomnia, and fatigue. Investigators will test a special mental health intervention called DESCANSO/REST (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep). The intervention can be delivered through telehealth.
Interventions
- Behavioral: DESCANSO/Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep; Rest in English — DESCANSO (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep; Rest in English)
Primary outcomes
- Number of participants who complete at least 5 DESCANSO sessions (Up to 1 year)
Eligibility information
Provider Eligibility Criteria:
Participant eligibility will be determined by a self-report screener. Inclusion Criteria Self-Report Criteria
* Mental health provider
* Treats Latino cancer patients and/or survivors
* Has at least 3 years of clinical experience providing psychosocial services to cancer patients and/or survivors
* Able to read Spanish determined by the question: "Can you read in Spanish? Yes/No"
Patient Eligibility Criteria:
A patient cannot be considered eligible for this study unless ALL of the following conditions are met. Participant eligibility will be determined by an initial EMR review followed by a self-report screener.
Inclusion Criteria EMR Criteria
* Documentation of Disease
o Pathologically confirmed solid tumor cancer (either most recent or new diagnosis)
* Definition of Disease \[or Measurable Disease\]
o Diagnosed with stages I, II, or III
* Prior Treatment
* Currently undergoing systemic therapy (chemotherapy, radiation therapy, and/or immunotherapy) or within the first year following completion of systemic therapy Self-Report Criteria
* Age ≥ 21 years
* Lives in mainland U.S. or Puerto Rico
* Identifies as Latino/a or Hispanic
* Reports Spanish as their preferred language
* Speaks Spanish "Very well" or "Well" as determined by the question: "How well do you speak Spanish?"
* Presence of fatigue and disturbed sleep determined by a score of ≥ 3 on the MD Anderson Symptom Inventory
Exclusion Criteria EMR Criteria
o In the judgment of the treating physician, protocol investigators, and/or study staff, presence of cognitive impairment (e.g., delirium or dementia) sufficient to preclude meaningful informed consent and/or study participation
Self-Report Criteria
* History of comorbidities within the last 12 months associated with fatigue and poor sleep, including hypothyroidism or abnormal thyroid function, sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, alcohol or drug abuse
* Pregnant or lactating, women only
* Presence of suicidal risk determined by any affirmative response on the Columbia-Suicide Severity Rating Scale
Study locations
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey 07920 United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey 07748 United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey 07645 United States
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack, New York 11725 United States
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York 10604 United States
- Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York 11553 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.